MANUFACTURERS LIFE INSURANCE COMPANY, THE - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,180,008
+59.6%
43,311
+30.3%
0.00%
Q2 2023$739,546
-2.4%
33,238
-5.0%
0.00%
Q1 2023$757,667
+6.9%
34,980
+0.2%
0.00%
Q4 2022$708,961
-20.0%
34,907
+1.0%
0.00%
-100.0%
Q3 2022$885,965
+6.1%
34,554
-1.6%
0.00%0.0%
Q2 2022$834,844
+0.5%
35,107
-4.8%
0.00%0.0%
Q1 2022$830,853
-14.6%
36,894
-24.9%
0.00%0.0%
Q4 2021$973,000
-1.2%
49,147
-1.8%
0.00%0.0%
Q3 2021$985,000
-18.8%
50,067
-9.2%
0.00%0.0%
Q2 2021$1,213,000
-7.5%
55,130
-0.1%
0.00%0.0%
Q1 2021$1,312,000
-14.2%
55,160
-5.6%
0.00%0.0%
Q4 2020$1,529,000
+56.8%
58,462
+4.4%
0.00%0.0%
Q3 2020$975,000
+0.9%
55,996
-2.9%
0.00%0.0%
Q2 2020$966,000
+32.7%
57,671
-5.8%
0.00%0.0%
Q1 2020$728,000
+4.0%
61,210
+5.8%
0.00%0.0%
Q4 2019$700,000
-83.8%
57,858
-80.4%
0.00%
-80.0%
Q3 2019$4,314,000
+527.9%
295,877
+379.9%
0.01%
+400.0%
Q2 2019$687,000
-83.0%
61,658
-82.1%
0.00%
-75.0%
Q1 2019$4,040,000
-12.1%
344,152
+0.1%
0.00%
-33.3%
Q4 2018$4,594,000
-15.6%
343,838
-11.4%
0.01%0.0%
Q3 2018$5,441,000
+3.0%
388,114
+15.5%
0.01%0.0%
Q2 2018$5,282,000
+10.3%
336,031
+15.5%
0.01%
+20.0%
Q1 2018$4,787,000
+12.0%
290,991
+22.9%
0.01%0.0%
Q4 2017$4,275,000
+23.1%
236,728
+31.5%
0.01%
+25.0%
Q3 2017$3,473,000
+62.3%
179,974
-0.8%
0.00%
+33.3%
Q2 2017$2,140,000
+225.2%
181,414
+201.7%
0.00%
+200.0%
Q1 2017$658,000
+70.9%
60,122
+13.4%
0.00%0.0%
Q4 2016$385,000
+9.7%
53,008
-1.7%
0.00%0.0%
Q3 2016$351,000
+19.4%
53,940
+0.2%
0.00%
Q2 2016$294,000
+53.9%
53,837
+20.7%
0.00%
Q1 2016$191,000
-12.0%
44,605
+2.1%
0.00%
Q4 2015$217,000
+36.5%
43,668
+2.9%
0.00%
Q3 2015$159,000
-37.6%
42,4410.0%0.00%
Q2 2015$255,000
+9.4%
42,441
+1.9%
0.00%
Q1 2015$233,000
+87.9%
41,668
+0.8%
0.00%
Q4 2014$124,000
+15.9%
41,355
+3.6%
0.00%
Q3 2014$107,000
+1683.3%
39,920
+1889.0%
0.00%
Q2 2014$6,000
-97.0%
2,007
-95.6%
0.00%
Q1 2014$200,000
+50.4%
45,749
+10.5%
0.00%
Q4 2013$133,000
+1377.8%
41,408
+667.5%
0.00%
Q3 2013$9,000
-25.0%
5,395
-21.8%
0.00%
Q2 2013$12,0006,9000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders